Attachments

European market disclosures, company announcements, and official source documents.

Information service only. Not investment advice.

Pentixapharm Holding AG Pentixapharm Holding AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | Phynwire

Pentixapharm Holding AG

Pentixapharm Holding AG Pentixapharm Holding AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Original source on eqs-news.com

Language:EnglishDE

Pentixapharm Holding AG / Total Voting Rights Announcement
Pentixapharm Holding AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
30.07.2026 / 22:46 CET/CEST
Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Publication of new total number of voting rights according to Sec. 41 WpHG
1. Details of issuer

Pentixapharm Holding AG
Robert-Rössle-Straße 10
13125 Berlin
Germany

2. Type of capital measure or other measure

	Type of capital measure or other measure	Date of status / date of effect
	Conditional capital increase (Sec. 41 para. 2 WpHG)
X	Other (capital) measure (Sec. 41 para. 1 WpHG)	30 Jul 2026

3. New total number of voting rights:

35815689
number of multiple voting rights thereof: 0

30.07.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Language:	English
Company:	Pentixapharm Holding AG
	Robert-Rössle-Straße 10
	13125 Berlin
	Germany
Internet:	https://www.pentixapharm.com/
LEI Code:	3912005VBOVXNDXEQZ36


End of News	EQS News Service

2375022 30.07.2026 CET/CEST